All In Biotech

Free tool

FAERS Monitor: Dexmedetomidine Hydrochloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 206628 or its brand name (Dexmedetomidine Hydrochloride, Dexmedetomidine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

5,243

Serious

5,001

95% of reports

Hospitalization

2,475

Death reported

568

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use608
  • drug ineffective450
  • bradycardia418
  • hypotension313
  • cardiac arrest263
  • drug interaction261
  • agitation202
  • product use in unapproved indication174
  • respiratory failure167
  • delirium153
  • pyrexia146
  • tachycardia146
  • toxicity to various agents143
  • acute kidney injury127
  • diabetes insipidus119

Reports by year received

View as table
YearReports
20051
20065
20071
20088
200918
201024
201129
201230
201390
2014103
201580
2016220
2017244
2018211
2019348
2020512
2021571
2022552
2023613
2024659
2025582
2026342

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,916 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
diabetes insipidusSignal119208.5173.823,170
bradycardiaSignal41831.929.112,401
deliriumSignal15317.815.22,397
cardiac arrestSignal26312.811.42,856
agitationSignal20211.19.71,840
respiratory failureSignal1679.27.91,215
drug interactionSignal2616.65.91,244
tachycardiaSignal1466.65.6690
hypotensionSignal3136.35.61,392
toxicity to various agentsSignal1433.42.9242
acute kidney injurySignal1273.32.8206
product use in unapproved indicationSignal1742.82.4204
off label useSignal6082.82.6724
pyrexia1461.71.441
drug ineffective4501.41.348

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.